The diagnosis of Huntington's disease by different molecular tools: a systematic review

Tiago César Gouvêa Moreira1,2, Carmen Lucia Antão Paiva1,3, Luciana Andrade Agostinho1,4

  • 1PPGNEURO (Programa de Pós-Graduação em Neurologia), Hospital Huniversitário Gaffrée e Guinle, Rua Mariz e Barros, Rio de Janeiro, Brazil.

Insights

Molecular diagnostic tools for Huntington's disease (HD) show varied validation. Thorough assessment of key parameters like sensitivity and specificity is crucial for accurate HD diagnosis and patient management.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG trinucleotide repeat expansion in the HTT gene.
  • Accurate molecular diagnostic tools are essential for early detection, genetic counseling, and clinical management of HD.
  • Current diagnostic methods for HD exhibit variability in their validation, potentially impacting reliability.

Purpose of the Study:

  • To review and analyze the validation methods of molecular diagnostic tools for Huntington's disease.
  • To identify the strengths and weaknesses of different molecular diagnostic techniques for HD.
  • To highlight the need for standardized validation protocols in HD molecular diagnostics.

Main Methods:

  • A systematic literature search was conducted using PubMed with keywords related to Huntington's disease and molecular diagnostic techniques.
  • The review adhered to PRISMA guidelines, and bias assessment followed Cochrane Handbook recommendations.
  • Nineteen articles presenting validation methods for HD molecular diagnostics were included in the analysis.

Main Results:

  • Significant variability was observed in the validation methods employed across the reviewed studies.
  • Only three studies reported comprehensive validation parameters including limits of detection, reproducibility, sensitivity, and specificity.
  • TPPCR coupled with capillary electrophoresis demonstrated high accuracy, while gel electrophoresis-based methods showed lower sensitivity and specificity.

Conclusions:

  • The lack of standardized validation for molecular diagnostic tools in Huntington's disease can compromise diagnostic accuracy.
  • Thorough validation, including assessment of sensitivity and specificity, is critical for reliable HD diagnosis.
  • Improved standardization of validation methods will enhance genetic counseling and clinical management of Huntington's disease.
Abstract